Develops drugs for gastrointestinal and neurological diseases.
Jun 2026Revenue $10.9B/yrExpenses $9.97B/yr
No trend
Figures by year
Is Bausch Health Companies profitable?
Yes. In the 12 months to Jun 2026, revenue was $10.9B and expenses $9.97B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $10.3B | $8.45B | $1.81B |
| Dec 2024 | $9.63B | $8.08B | $1.55B |
| Dec 2023 | $8.76B | $7.79B | $963M |
| Dec 2022 | $8.12B | $7.67B | $454M |
| Dec 2021 | $8.43B | $7.98B | $450M |
| Dec 2020 | $8.03B | $7.35B | $676M |
| Dec 2019 | $8.60B | $8.80B | −$203M |
| Dec 2018 | $8.38B | $10.8B | −$2.38B |
| Dec 2017 | $8.72B | $8.62B | $102M |
| Dec 2016 | $9.67B | $10.2B | −$566M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.